Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M647Revenue (TTM) $M101Net Margin (%)-56.0Altman Z-Score0.5
Enterprise Value $M557EPS (TTM) $-0.6Operating Margin %-53.8Piotroski F-Score5
P/E(ttm)--Beneish M-Score-0.9Pre-tax Margin (%)-56.0Higher ROA y-yN
Price/Book6.410-y EBITDA Growth Rate %--Quick Ratio3.3Cash flow > EarningsY
Price/Sales5.65-y EBITDA Growth Rate %-45.7Current Ratio3.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-41.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-69.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M92.7ROIC % (ttm)-424.0Gross Margin Increase y-yY

Gurus Latest Trades with PACB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PACBRonald Muhlenkamp 2015-12-31 Sold Out -0.01%$6.13 - $13.45
($9.11)
$ 6.98-23%Sold Out0
PACBRonald Muhlenkamp 2015-09-30 Buy 0.01%$3.66 - $5.8
($4.89)
$ 6.9843%New holding11,125
PACBFirst Eagle Investment 2012-09-30 Sold Out -0.0013%$1.7 - $2.32
($1.96)
$ 6.98256%Sold Out0
PACBFirst Eagle Investment 2012-03-31 Buy $2.94 - $5.04
($3.71)
$ 6.9888%New holding150,000
PACBGeorge Soros 2011-09-30 Sold Out -0.0018%$3.55 - $12.24
($7.91)
$ 6.98-12%Sold Out0
PACBGeorge Soros 2011-06-30 Buy $10.44 - $13.53
($11.8)
$ 6.98-41%New holding10,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PACB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


PACB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Phillips James MichaelSVP, Research & Development 2016-10-28Sell20,000$8.44-17.77view
Phillips James MichaelSVP, Research & Development 2016-07-29Sell20,000$8.45-17.87view
Phillips James MichaelSVP, Research & Development 2016-04-25Sell20,000$10.29-32.56view
Phillips James MichaelSVP, Research & Development 2015-08-07Sell16,689$4.6150.54view
Phillips James MichaelSVP, Research & Development 2015-03-02Buy1,877$4.9141.34view
CORCORAN KEVIN PSVP, Market Development 2015-03-02Buy2,816$4.9141.34view
Dow Brian BVP and PAO 2015-03-02Buy2,503$4.9141.34view
Ericson William W.Director 2014-08-19Buy39,299$5.1435.02view
Ericson William W.Director 2014-08-18Buy135,155$5.0936.35view
Ericson William W.Director 2014-08-14Buy77,822$538.8view

Quarterly/Annual Reports about PACB:

News about PACB:

Articles On GuruFocus.com
Meridian Funds Comments on Pacific Biosciences of California Inc. Mar 08 2016 
Weekly CEO Buys Highlight: CLR, CLMS, OPK, PACB, GAIN Dec 16 2013 
Weekly CEO Buys Highlight: OPK, PACB, CUBI, ARCP, RLYP Nov 25 2013 
Weekly CEO Buys Highlight: PHII, TUES, PACB, IPHI, WMC Dec 09 2012 
Weekly CEO Buys Highlight: PACB, AKS, EPIQ, GGS, TPGI Dec 02 2012 
Weekly CEO Buys Highlight: FFIN, STEC, MPO, PACB, TPGI Nov 25 2012 
Weekly CEO Buys Highlight: SUNS, PACB, GM, NPO, DGX Aug 11 2012 

More From Other Websites
ETFs with exposure to Pacific Biosciences of California, Inc. : November 28, 2016 Nov 28 2016
Pacific Biosciences of California, Inc. :PACB-US: Earnings Analysis: Q3, 2016 By the Numbers :... Nov 18 2016
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Financials Nov 11 2016
Pacific Biosciences (PACB) Q3 Loss Narrower than Expected Nov 07 2016
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 10-Q, Quarterly Report Nov 04 2016
Health Sector Down As Report of Industry Price Collusion Surfaces Nov 03 2016
Edited Transcript of PACB earnings conference call or presentation 2-Nov-16 8:30pm GMT Nov 02 2016
PacBio Files ITC Patent Infringement Complaint Against Oxford Nanopore Nov 02 2016
Pacific Biosciences of California, Inc. Announces Third Quarter 2016 Financial Results Nov 02 2016
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 8-K, Results of Operations and Financial... Nov 02 2016
Pacific Biosciences of California, Inc. Announces Third Quarter 2016 Financial Results Nov 02 2016
PacBio Files ITC Patent Infringement Complaint Against Oxford Nanopore Nov 02 2016
Q3 2016 Pacific Biosciences of California Inc Earnings Release - After Market Close Nov 02 2016
Pacific Biosciences (PACB): What's Up this Earnings Cycle? Oct 31 2016
Pacific Biosciences of California, Inc. breached its 50 day moving average in a Bearish Manner :... Oct 27 2016
ETF’s with exposure to Pacific Biosciences of California, Inc. : October 19, 2016 Oct 19 2016
Novel Human Genetics Discoveries Using PacBio Long-Read Sequencing to be Presented at ASHG Annual... Oct 17 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)